Newsletter Subject

Neurologic Conditions Now Leading Cause of Disability Worldwide

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Fri, Mar 15, 2024 10:47 PM

Email Preheader Text

Daily Headlines Friday, March 15, 2024 Today's Top Stories for {NAME} THE BREAK ROOM CME SPOTLIGHT T

[MEDPAGE TODAY]( Daily Headlines Friday, March 15, 2024 Today's Top Stories for {NAME} [NEUROLOGY]( [Neurologic Conditions Now Leading Cause of Disability Worldwide]( [INFECTIOUS DISEASE]( [Long COVID Patients, Advocates Rally for More Research, Funding, and Attention]( [PUBLIC HEALTH & POLICY]( [EPA Imposes New Limit on Medical Sterilization Chemical, Citing Cancer Risk]( THE BREAK ROOM [Spell Check-Up: Try to Pass This Spelling Quiz]( CME SPOTLIGHT [Applying the Latest Clinical Evidence to Treatment Plans for Pediatric Patients With Hodgkin Lymphoma]( [SPECIAL REPORTS]( [Match Rates Stable as Applicants, Positions Reach All-Time Highs]( [ONCOLOGY/HEMATOLOGY]( [FDA Approves First CAR-T for Chronic Lymphocytic Leukemia]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [PUBLIC HEALTH & POLICY]( [MedPAC's Report Recommends Pay Changes for Healthcare Services]( CME SPOTLIGHT [Hitting the Mark? Targeted Antibody-Based Therapy for Diffuse Large B-Cell Lymphoma]( [NEPHROLOGY]( [EHR Alerts Trigger Primary Care Clinics to Improve Hypertension Care in CKD]( [PEDIATRICS]( [CDC: Cases of MIS-C After COVID Still Occurring in U.S. Kids]( [OB/GYN]( [Is the U.S. Overcounting Maternal Deaths? New Study Stirs Controversy]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Advancing cTTP Care Through Integration of the Latest Clinical Evidence]( [MEETING COVERAGE]( [Topical Nonsteroid Gets High Marks for Youngsters With Atopic Dermatitis]( [AAD READING ROOM]( [Platelet-Rich Plasma Is Popular, But Evidence of Efficacy Is Scant]( [OB/GYN]( [In a First, Vice President Harris Visits a Clinic That Performs Abortions]( CME SPOTLIGHT [Advancing Collaborative Multiple Myeloma Care Coordination Among Oncology Centers]( [WASHINGTON-WATCH]( [How Can the U.S. Prevent Future Cyberattacks Like the One on Change Healthcare?]( [PODCASTS]( [MedPod Today: AAMC Leaked Emails; 'Wild West' of Ketamine; MA Games the System]( [SPECIAL REPORTS]( [FDA Tries to Close the Lid on Poop Transplant Company]( CME SPOTLIGHT [Navigating the Nuances of von Hippel-Lindau (VHL) Disease Care: A Clinical Challenge in Treatment and Management]( [MEDICAL JOURNEYS]( [Chronic Spontaneous Urticaria and Autoimmunity]( [MEDICAL JOURNEYS]( [For Your Patients: How Will My Doctor Diagnose Hives?]( [ONCOLOGY/HEMATOLOGY]( [New PD-1 Inhibitor Approved for Esophageal Cancer]( CME SPOTLIGHT [Supporting Patients in Navigating Novel Therapies for Multiple Myeloma Treatment]( [MEDICAL JOURNEYS]( [Breast Cancer Palliative Care and Metastatic Disease: Looking Beyond End of Life]( [MEDICAL JOURNEYS]( [For Your Patients: Understanding Palliative Care for Breast Cancer]( # Weekly Survey [Should It Be Easier for IMGs to Get Medical Licenses?]( More states are creating [alternative pathways to residency]( for international medical graduates (IMGs), including skipping U.S. residency in certain cases[VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2024 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2024-03-15&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.